SRxA’s Word on Health has often reported on the price of non-adherence to treatment . So, although we were shocked, we weren’t surprised to learn that poorly controlled asthma doubles costs and affects children’s performance in school.
According to a study just published in the Annals of Allergy, Asthma and Immunology children with very poorly controlled asthma miss an average of 18 days from the classroom; whereas kids whose disease is better controlled, are absent for two days or less.
The investigators from National Jewish Hospital studied 628 children aged 6-12 with severe asthma. They looked at direct medical costs such as medications, unscheduled doctor visits, emergency department visits and hospital admissions as well as the indirect costs such as school days lost.
Patients were divided into three groups: very poorly controlled, not well controlled and well controlled. Costs were evaluated at the start of the study and then one and two years later.
The group, led by Stanley Szefler MD found that the costs for very poorly controlled patients were twice as high as those of the other groups at baseline. Very poorly controlled patients cost $7,846, compared with $3,526 for not-well controlled and $3,766 for well-controlled.
Two years later the costs for the very poorly controlled group had risen to $8,880 while costs for those with well-controlled asthma dropped to $1,861. Indirect costs accounted for approximately half the total asthma costs for very poorly controlled asthma patients at each time point.
The authors concluded that very poorly controlled asthma is a major economic burden and improvement in asthma control and is associated with reducing cost.
SRxA together with our expert Allergy and Pulmonary Advisors can help pharmaceutical companies promote better management strategies that may significantly reduce this burden of illness. For more information, contact us today.